Lung Cancers Recruiting Phase 1 / 2 Trials for Tremelimumab (DB11771)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03212469A Trial of Durvalumab and Tremelimumab in Comibination With SBRT in Patients With Metastatic CancerTreatment